CIK 0001680367
- Non-accelerated filer
- Smaller reporting company
Shattuck Labs, Inc.
Sign in to watch- Ticker
- STTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812575858
- Phone
- +1 512-900-4690
- Business address
- 500 W. 5TH STREET, AUSTIN, TX, 78701
- Former names
- Shattuck Labs, Inc.
- 4 Open-market buy Director bought 28,330 shares at $3.63 ($102,838)
- 4 Open-market buy Director bought 26,283 shares at an average $3.69 ($96,980)
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Chief Executive Officer acquired 3,926 shares (option exercise)
- 4 Open-market buy Director bought 8,000 shares at an average $7.00 ($56,035)
- 4 Grant or award Chief Business Officer acquired 21,363 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 34,738 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 33,325 shares (grant or award)
- 4 Option exercise General Counsel acquired 10,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Chief Financial Officer acquired 20,000 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 3,926 shares (option exercise)
- 4 Open-market sale General Counsel sold 33,000 shares at $19.50 ($643,500)
- 4 Option exercise Chief Financial Officer acquired 2,203 shares (option exercise)
- 4 Option exercise Chief Medical Officer acquired 4,259 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 3,926 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 2,000 shares at $22.13 ($44,263)
- 4 Open-market sale General Counsel sold 2,000 shares at $22.18 ($44,367)
Page 7 of 11 · 211 filings